Cerca una sperimentazione clinica
Altra/e opzione/i di ricerca
28 Risultato/i
Sperimentazione in fase di reclutamento
= 
; Sperimentazione in corso
= 
; Finanziato da un ente associato a IRDiRC = 
; Membro di una ERN = 
Sperimentazioni cliniche nazionali
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - AT
Institution: Information not provided - AT
FRANCIA
NOUVELLE AQUITAINE
BORDEAUX
A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas (Phase II)
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes
FRANCIA
NOUVELLE AQUITAINE
BORDEAUX
METZOLIMOS : A phase Ib study of metronomic Cyclophosphamide and Methotrexate combined with Zoledronic acid and Sirolimus in patients with solid tumor with bone metastasis and advanced pretreated Osteosarcoma
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes
GERMANIA
Baden-Württemberg
HEIDELBERG
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie
GERMANIA
Baden-Württemberg
HEIDELBERG
Phase I/II therapy trial to determine the safety and efficacy of heavy Ion Radiotherapy in patients with Osteosarcoma - DE
Neurologische Universitätsklinik Heidelberg
Klinik für Radioonkologie und Strahlentherapie
GERMANIA
Baden-Württemberg
STUTTGART
EURAMOS I: A randomized trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable Osteosarcoma based on histological response to pre-operative chemotherapy (Phase III)
Klinikum Stuttgart - Standort Olgahospital
COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale
GERMANIA
Baden-Württemberg
STUTTGART
EURO-B.O.S.S.: A European treatment protocol for bone sarcoma in patients older than 40 years - DE
Klinikum Stuttgart - Standort Olgahospital
COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale
GERMANIA
Bayern
REGENSBURG
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation
GERMANIA
Nordrhein-Westfalen
ESSEN
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie
ITALIA
EMILIA ROMAGNA
BOLOGNA
Studio clinico multicentrico, randomizzato, di fase II per il trattamento dei pazienti con osteosarcoma in recidiva
Istituto Ortopedico Rizzoli - Centro di Ricerca e Poliambulatorio
S.C. Laboratorio di Oncologia Sperimentale
SPAGNA
Andalucía
SEVILLA
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)
SPAGNA
Andalucía
SEVILLA
GEIS-52: Phase I-II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)
SPAGNA
Andalucía
SEVILLA
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Universitario Virgen del Rocío
Servicio de Oncología pediátrica
SPAGNA
Cataluña
BADALONA
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Oncología Médica
SPAGNA
Cataluña
BARCELONA
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Universitari Vall d'Hebron
Servicio de Oncología y Hematología Pediátricas
SPAGNA
Cataluña
ESPLUGUES DE LLOBREGAT
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Sant Joan de Déu Barcelona
Servicio de Oncología y Hematología
SPAGNA
Comunidad Valenciana
VALENCIA
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Universitario y Politécnico La Fe
Unidad de Oncohematología Pediátrica
SPAGNA
Madrid
MADRID
Phase 1/2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología
SPAGNA
Madrid
MADRID
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología
SPAGNA
Madrid
MADRID
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Universitario La Paz
Servicio de Hemato-oncología pediátrica
SPAGNA
País Vasco
BARAKALDO
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE) - ES
Hospital Universitario Cruces
Unidad de Oncología Pediátrica
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
PARITY (Prophylactic Antibiotic Regimens in Tumor Surgery): A Multi-Center International Randomized Controlled Trial Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections With Endoprosthetic Replacements (Phase 3) - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors (Phase 2) - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
WIEN
INFORM2 NivEnt: Exploratory Multinational Phase I/II Combination Study of Nivolumab and Entinostat in Children and Adolescents With Refractory High-risk Malignancies - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde
SPAGNA
Madrid
MADRID
Randomized, double-blind, 3-arm trial to evaluate the impact of blood loss following administration of three tranexamic acid regimens in patients undergoing bone or soft tissue sarcomas (Phase III) - ES
IdiPAZ - Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Unidad Central de Investigación Clínica y Ensayos Clínicos del Hospital La Paz
BELGIO
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique
Sperimentazioni cliniche internazionali
FRANCIA
AUVERGNE-RHONE-ALPES
LYON
EUROSARC: European Clinical trials in Rare Sarcomas within an integrated translational trial network
CLCC Léon Bérard
Centre Léon Bérard
SVIZZERA
Suisse Alémanique
BASEL